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G protein-coupled receptors are well recognized as being able to activate several signaling
pathways through the activation of different G proteins as well as other signaling pro-
teins such as β-arrestins. Therefore, understanding how such multiple GPCR-mediated
signaling can be integrated constitute an important aspect. Here, we applied biolumines-
cence resonance energy transfer (BRET) to shed more light on the G protein coupling
profile of trypsin receptor, or protease-activated receptor 2 (PAR2), and its interaction with
β-arrestin1. Using YFP and Rluc fusion constructs expressed in COS-7 cells, BRET data
revealed a pre-assembly of PAR2 with both Gαi1 and Gαo and a rapid and transient acti-
vation of these G proteins upon receptor activation. In contrast, no pre-assembly of PAR2
with Gα12 could be detected and their physical association can be measured with a very
slow and sustained kinetics similar to that of β-arrestin1 recruitment. These data demon-
strate the coupling of PAR2 with Gαi1, Gαo, and Gα12 in COS-7 cells with differences in
the kinetics of GPCR-G protein coupling, a parameter that very likely influences the cellular
response. Moreover, this further illustrates that pre-assembly or agonist-induced G protein
interaction depends on receptor-G protein pairs indicating another level of complexity and
regulation of the signaling of GPCR-G protein complexes and its multiplicity.
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INTRODUCTION
Recently the study of the interaction of GPCRs with their specific
signaling and regulatory proteins has been widely studied using
energy transfer-based approaches BRET and FRET (biolumines-
cence/fluorescence resonance energy transfer) (1–5). These meth-
ods allow the measurements, in real-time and live cells, of either
the recruitment of specific proteins (i.e., G protein subunits, RGS,
arrestins, GRKs . . .) to the activated receptor or conformational
changes within their preassembled or newly formed complexes
(6–10). Consequently, interesting conclusions have been reported
regarding GPCR-G protein coupling, interaction between G pro-
tein subunits, and GPCR-arrestin association in terms of struc-
ture,pharmacology,and kinetic of activation/deactivation. Indeed,
many studies have shown the possibility of GPCRs to form pre-
assembled complexes even in the absence of receptor activation
[for review (1, 3)]. However, others clearly demonstrate that
receptor-G protein association is exclusively mediated by agonist
activation with expected or unexpected kinetics [for review (1, 3)].
One of the important GPCR families is protease-activated
receptors (PARs) which is composed by four subtypes, PAR1,
protease-activated receptor 2 (PAR2), PAR3, and PAR4, which play
crucial roles in a number of physiological processes such as throm-
bosis, vascular development, cell proliferation, and tumorigenesis
(11). Therefore they are considered as interesting targets for the
treatment of various pathologies like inflammation, cancer, and
stroke (12). PARs are known to be activated by various serine pro-
teases such as thrombin, trypsin, plasmin, and the factor Xa (13,
14). PARs activation occurs through a highly specific protease-
mediated cleavage of the N-terminal extremity of the receptor
unmasking a new N terminus that acts as a tethered ligand which
directly activates the transmembrane core of the cleaved receptor
(13–15). PARs are characterized by the diversity and overlapping
of their signaling pathways involving various G protein classes:
Gαi/o, Gαq/11, Gα12/13 proteins as well as arrestins promoting
multiple downstream signaling responses in various cellular mod-
els (15–19). Furthermore, PARs undergo a rapid desensitization,
internalization, and degradation involving the phosphorylation
of the receptor by G protein-coupled receptor kinases and the
recruitment of arrestins (18, 19). However, except for the proto-
type member, PAR1, the G protein coupling profile of the different
members of PARs is not really a consensus matter and little infor-
mation is available regarding their coupling to G proteins. This is
true for PAR2 which is typically Gαq/11-coupled receptor leading
to an increase in intracellular calcium via PLC/IP3 pathway (16,
18, 20, 21). However, a study in the Xenopus oocyte system has
reported that PAR2-mediated intracellular signaling events were a
pertussis toxin (PTX)-sensitive indicating a role of PAR-Gαi/Gαo
coupling (22). Also, PAR2 activation in the epithelial cells elicited
a calcium response in both PTX-sensitive and PTX-insensitive
depending on the cell model used (23). Recently PAR2 activating
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peptide SLIGRL has been shown to induce smooth muscle con-
traction by triggering the activation of Gαq, Gαi1, and Gα13 (24).
However, it has been shown that PAR2, in contrast to PAR1, does
not couple to Gαi and Gαo families in COS-7 cells (25). Together,
these studies indicate that the pattern of G protein coupling of
PAR2 strongly depends on the cellular model considered since the
differences can be due to factors such receptor density, the avail-
ability of G proteins and other interacting proteins . . . etc. [For
review (1)].
Many recent studies have used BRET to investigate GPCR-G
protein coupling (1, 3) including PARs (6, 7, 26). Indeed, our
recent data using both BRET and time-resolved FRET (TR-FRET)
technologies revealed the existence of preassembled complexes
between PAR1 and Gαi1 protein (6, 7), as well as Gαo (27) in COS-
7 cells. In contrast, the physical association of PAR1 with Gα12, but
not Gα13, was exclusively observed upon receptor activation with
a very slow and stable kinetic indicating the recruitment of Gα12
to the activated PAR1 in parallel to β-arrestin1 recruitment (7). In
this study, we aimed to investigate the physical interaction of PAR2
with Gαi1, Gαo, Gα12, and β-arrestin1 before and upon receptor
activation by BRET, in real-time and live cells, using Rluc-tagged
Gα proteins and YFP-tagged PAR2.
MATERIALS AND METHODS
MATERIALS AND PLASMID CONSTRUCTIONS
Human cDNA for PAR2 were cloned into pcDNA3.1+ (Guthrie
Research Institute, Sayre, PA, USA). PAR2-YFP fusion protein and
Rluc-tagged G proteins were generated as previously described
(6). PAR2-∆C-YFP mutant corresponds to the δ Tail mutant
reported by Seatter et al. removing the entire C-terminus from
Serine 348 (28). Such truncation was generated using the sim-
ilar strategy for PAR1-∆C-YFP previously reported (6). Rluc-
β-arrestin1 were generously provided by M. G. Scott (Insti-
tut Cochin, Paris, France). Bovine trypsin pancreas was from
Calbiochem Merck KgaA (Darmstadt, Germany) and Ser-Leu-
Iso-Gly-Arg-Leu-NH2 (SLIGRL) peptide was from Tocris Cook-
son Inc., Ellisville, MO, USA. Ninety-six-well white microplates
were from Greiner Bio-One SAS (Courtaboeuf, France). Coe-
lenterazine h substrate was from Promega (Charbonnières,
France).
CELL CULTURE AND TRANSFECTION
COS-7 cells were grown in complete medium [DMEM sup-
plemented with 10% (v/v) fetal bovine serum, 4.5 g/l glucose,
100 U/ml penicillin, 0.1 mg/ml streptomycin, and 1 mM gluta-
mine] (all from Invitrogen, Carlsbad, CA, USA). Transient trans-
fections were performed by reverse transfection in 96-well plate
using Lipofectamine 2000 following the manufacturer’s proto-
col. Briefly, for each well the different combinations of coding
plasmids were used as follow: 25 ng of PAR2-YFP (WT and
∆C mutant), 50 ng of Gαi1/o-Rluc or Rluc-β-arrestin 1, and
150 ng of Gα12-Rluc. The plasmid mixes and Lipofectamine 2000
(0.5µl/well) were first preincubated 5 min at room temperature
in serum-free DMEM (2× 25µl/well). Then the two solutions
of serum-free DMEM containing plasmids and Lipofectamine
were mixed and incubated 20 min at room temperature. Cells
(105 in 150µl/well) in DMEM supplemented with 10% FCS
were then incubated with the final plasmid-Lipofectamine mix
(50µl/well).
BRET MEASUREMENTS
Forty-eight hours after transfection cells were washed with PBS
and preincubated in the absence or presence of trypsin or SLIGRL
as indicated in PBS at 37°C. Cells were then washed and resus-
pended in PBS for BRET measurements. The kinetic and dose-
response analysis of BRET signals was performed as described
previously (6). The BRET Ratio was defined as the subtraction
of the ratio of the emission at 530± 25 nm over the emission
at 485± 20 nm of cells expressing the Rluc fusion protein alone
from the same ratio of cells co-expressing Rluc and YFP fusion
proteins. Then the resulted values were multiplied by 1000. How-
ever, the ligand-induced BRET was calculated by subtracting the
BRET Ratio for a PBS-treated cell sample from the same ratio for
the aliquot of the same cells treated with agonist. In this calcula-
tion only ligand-promoted BRET changes are represented and the
PBS-treated cell sample represents the background eliminating the
requirement for measuring an Rluc-only control sample especially
when fast kinetics and dose-response analysis are performed.
DATA ANALYSIS
All data were represented using Prism GraphPad software (San
Diego, CA, USA). Kinetic and dose-response curves were fitted
with non-linear regression equations using the different equations
as indicated.
RESULTS
BASAL AND LIGAND-INDUCED BRET BETWEEN PAR2 AND Gα
PROTEINS
The pattern of G protein coupling for PAR2 is still not completely
clarified when compared to PAR1 which is known to activate Gαo,
Gαi1/2, Gαq as well as Gα12/13 pathways in various in vitro and
in vivo models (14, 29). Therefore, we wanted to investigate the
putative coupling of PAR2 with Gαi1, Gαo, and Gα12, as this
has been previously demonstrated for PAR1 (6, 7, 27). For this,
we used BRET approach allowing real-time assessment of the
receptor-G protein complexes in live cells and BRET measure-
ments were performed in COS-7 cells transiently co-expressing
Gα-Rluc and PAR2-YFP fusion proteins and stimulated or not
with its specific agonist, trypsin. As shown in Figure 1A, signifi-
cant constitutive BRET signal was measured between PAR2-YFP
and either Gαi1-Rluc or Gαo-Rluc compared to Gα12-Rluc. This
was observed at similar relative expression levels of PAR2-YFP
as well as Rluc-tagged G proteins measured by fluorescence and
luminescence, respectively (Figure 1B). Interestingly, the stimu-
lation with 100 nM of trypsin for 2 min (for Gαi and Gαo) or
30 min for (Gα12) specifically increased the BRET signal between
all the Gα-Rluc and PAR2-YFP indicating functional coupling of
PAR2 with Gαi1, Gαo, and Gα12 (Figure 1A). Together, these data
suggest a possible pre-assembly between PAR2 and Gαi1 and Gαo,
but not Gα12. The agonist-induced BRET increase clearly demon-
strates a functional coupling of PAR2 with these G proteins which
is characterized by conformational changes within the preassem-
bled PAR2-Gαi1 and PAR2-Gαo complexes and probably Gα12
recruitment as previously shown for PAR1 (6, 7, 27).
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FIGURE 1 | Bioluminescence resonance energy transfer between PAR2
and Gα proteins in live COS-7 cells. (A) BRET measurements in COS-7
cells co-expressing PAR2-YFP and either Gαi1-Rluc, Gαo-Rluc, or Gα12-Rluc
in the absence () and presence of stimulation with 100 nM of trypsin ()
for 2 min (for Gαi and Gαo) or 30 min for (Gα12). (B) Quantification of the
luciferase (Rluc) activity () and YFP fluorescence () of BRET partners
measured in BRET assay. Data are means±SEM of three independent
experiments performed in triplicate.
KINETIC ANALYSIS OF LIGAND-INDUCED BRET BETWEEN PAR2 AND
Gα PROTEINS
Next, we performed real-time kinetics before and after agonist
addition using the injection system available on the Mithras LB-
490. As result, the injection of 100 nM of trypsin rapidly increased
the BRET signal between PAR2-YFP and Gαi1-Rluc (Figure 2A)
as well as Gαo-Rluc (Figure 2B) and the increased signal remained
stable ~5 min after ligand injection. The t 1/2 values are in second
interval as indicated in Table 1. However, no ligand-induced BRET
increase was observed between PAR2-YFP and Gα12-Rluc within
the first 4 min post-stimulation (Figure 2C). These observations
are comparable to what we previously reported on PAR1-Gαi1
coupling (6, 7) indicating similar pre-assembly properties and
activation kinetics.
Next, we performed long-term kinetics (up to 15–20 min) in
the absence or presence of trypsin stimulation. As shown above,
for both Gαi1-Rluc (Figure 3A) and Gαo-Rluc (Figure 3C) we
observed a basal BRET signal and trypsin promoted a rapid BRET
increase in the first seconds of stimulation and the signal was sta-
ble for ~4 min before its slow decline in a time-dependent manner.
The kinetic analysis using “Plateau followed by one phase decay”
equation of Prism GraphPad software resulted in decay t 1/2 val-
ues close to 10 min (Table 1) for both Gαi1-Rluc (Figure 3B) and
FIGURE 2 | Kinetic analysis of ligand-induced BRET increase between
PAR2 and Gα proteins. COS-7 cells transiently co-expressing PAR2-YFP
and either Gαi1-Rluc (A), Gαo-Rluc (B), or Gα12-Rluc (C) were used for
BRET experiments and repetitive signals were recorded before and
immediately after the injection of 100 nM of trypsin. The curves were fitted
using “Plateau then increase to top” equation of Prism GraphPad software
and Y = IF[X <X 0, Plateau, Plateau+ (Top−Plateau)*(1−exp(−K *
(X−X 0)))] constraining the plateau to a theoretical value of 0. Data are
mean±SEM of three independent experiments performed in single points.
Table 1 | t1/2 Values of trypsin-induced BRET increase signals and its
decline.
BRET combinations BRET increase BRET decline
Gαi1-Rluc+PAR2-YFP 3.31±0.81 s 9.82±0.38 min
Gαo-Rluc+PAR2-YFP 1.80±0.40 s 9.96±0.57 min
Gα12-Rluc+PAR2-YFP 4.94±0.53 min ND
Rluc-β-arrestin 1+PAR2-YFP 1.72±0.29 min ND
3.29±0.04 mina
at1/2 Value for SLIGRL. Data are mean±SEM (n=3).
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FIGURE 3 | Long-term kinetic analysis of trypsin-induced BRET increase
between PAR2 and Gα proteins. COS-7 cells transiently co-expressing
PAR2-YFP and either Gαi1-Rluc (A,B) or Gαo-Rluc (C,D) or Gα12-Rluc
(E,F) were used for BRET experiments in the absence () or presence of
100 nM of trypsin (•). For this, repetitive signals were recorded every ~35 s
immediately after trypsin addition during 18–20 min. The panels
(B,D,F) represent the Prism GraphPad fits of trypsin-induced BRET increase
using either “Plateau followed by one phase decay” equation (Y = IF[X <X 0,
Y 0, Plateau+ (Y 0−Plateau)*exp(−K *(X−X 0))]) constraining the plateau to a
theoretical value of 0 for Gαi1 and Gαo or “One phase exponential
association” equation (Y =Y max*(1−exp(−K *X )) for Gα12. Data are
mean±SEM of three independent experiments performed in single points.
Gαo-Rluc (Figure 3D). This analysis demonstrates a reversible
trypsin-induced BRET increase reflecting a rapid activation of
PAR2-Gαi1 and PAR2-Gαo complexes which is then likely fol-
lowed by their desensitization. In contrast, a very low BRET signal
was measured between Gα12-Rluc and PAR2-YFP as expected
(Figure 3E) consistent with the data in Figure 1A. Interestingly,
in the presence of trypsin we observed a gradual increase in
the BRET signal between Gα12-Rluc and PAR2-YFP (Figure 3E)
which reached a plateau after 15 min of stimulation (Figure 3F)
with a t 1/2 value close to 5 min (Table 1).
Together, our data indicate a pre-assembly of PAR2 with
Gαi1 and Gαo but not Gα12 and nicely demonstrate the rapid
agonist-promoted activation of the preassembled PAR2-G pro-
tein complexes. For Gαi1 and Gαo BRET increase likely reflects
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FIGURE 4 | Dose-response analysis of trypsin-induced BRET increase
between PAR2 and Gα proteins. COS-7 cells transiently co-expressing
PAR2-YFP and either Gαi1-Rluc (A), Gαo-Rluc (B), or Gα12-Rluc (C) were
used for BRET experiments in the presence of increasing concentrations of
trypsin as indicated. Data are means±SEM of three independent
experiments performed in duplicate.
conformational changes within the preassembled complexes lead-
ing to their activation followed by their time-dependent desen-
sitization. In contrast, the kinetic data with Gα12 suggest a
delayed recruitment in time-dependent manner of the G pro-
tein to the activated PAR2. All these observations are in fact
consistent with our previous data on PAR1-Gαi1 coupling (6, 7)
suggesting similar profile and properties with regard to G protein
coupling.
DOSE-RESPONSE ANALYSIS OF LIGAND-INDUCED BRET INCREASE
BETWEEN PAR2 AND Gα PROTEINS
To further profile PAR2-G protein interactions and demon-
strate the specificity of ligand-induced BRET increase between
FIGURE 5 | Dose-response analysis of SLIGRL-induced BRET increase
between PAR2 and Gα proteins. COS-7 cells transiently co-expressing
PAR2-YFP and either Gαi1-Rluc (A), Gαo-Rluc (B), or Gα12-Rluc (C) were
used for BRET experiments in the presence of increasing concentrations of
SLIGRL as indicated. Data are means±SEM of three to four independent
experiments performed in duplicate.
Rluc-tagged Gα and PAR2-YFP being associated to the activation
of receptor-G protein complex we carried out dose-response
analysis. After stimulation of cells with increasing doses of
trypsin according to the kinetic profile of Gαi1-Rluc, Gαo-
Rluc, and Gα12-Rluc, shown in Figure 3, a significant BRET
increase was measured in a dose-dependent manner for Gαi1-
Rluc/PAR2-YFP (Figure 4A), Gαo-Rluc/PAR2-YFP (Figure 4B),
or Gα12-Rluc/PAR2-YFP (Figure 4C) complexes. To further
demonstrate the specificity of trypsin effects, we also per-
formed dose-response experiments using PAR2-selective pep-
tide agonist, SLIGRL, which does not require receptor cleav-
age to activate PAR2 (20). As shown in Figure 5, SLIRGL
also induced a significant BRET increase was measured in a
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Table 2 | pEC50 values of trypsin and SLIGRL on BRET signals.
BRET combinations Trypsin SLIGRL
Gαi1-Rluc+PAR2-YFP 8.61±0.08 (n=3) 4.86±0.31 (n=4)
Gαo-Rluc+PAR2-YFP 8.03±0.18 (n=3) 5.18±0.26 (n=4)
Gα12-Rluc+PAR2-YFP 8.31±0.29 (n=3) 5.14±0.37 (n=3)
Rluc-β-arrestin 1+PAR2-YFP 7.86±0.11 (n=3) 4.91±0.07 (n=3)
Data are mean±SEM (n=3–4).
dose-dependent manner between Gαi1-Rluc (Figure 5A), Gαo-
Rluc (Figure 5B), or Gα12-Rluc (Figure 5C) and PAR2-YFP.
Both trypsin and SLIGRL increased BRET signals with their
expected and respective potencies (20) consistent with ligand-
induced BRET increase being reflecting PAR2-G protein complex
activation (Table 2).
LIGAND-INDUCED RECRUITMENT OF β-ARRESTIN 1 TO PAR2
Finally, we examined the interaction of PAR2 with β-arrestin
1 using BRET. Indeed, the activation of PAR2 is known to be
followed by its desensitization and phosphorylation at multiple
serine/threonine residues in the C-terminal tail (18, 28, 30). Such
phosphorylation constitutes a key step for β-arrestin recruitment
to PAR2 promoting receptor internalization through clathrin-
coated pits (30). As expected no significant basal BRET can be
measured Rluc-β-arrestin 1 and PAR2-YFP and both 100 nM
of trypsin (Figure 6A) and 10µM SLIGRL (Figure 6B) nicely
increased BRET signals. The BRET increase was time-dependent
before it reached a plateau corresponding to a saturation of all
the phosphorylated PAR2 with the recruited β-arrestin 1. After
normalization of the data in Figures 6A and 6B to the percent-
age of maximal BRET in each case we noticed a slight shift in
the kinetics between trypsin and SLIGRL curves (Figure 6C)
with the t 1/2 values indicated in Table 1. This difference in
the kinetics may be due to differences in the binding and acti-
vation properties of trypsin and SLIGRL. To demonstrate the
specificity of the ligand-induced BRET increase as well as the
requirement of PAR2 phosphorylation for β-arrestin 1 recruit-
ment, we used a mutant of PAR2 (PAR2-∆C-YFP) lacking a
large part of its C-terminus (from serine 348) containing mul-
tiple serine/threonine residues (28). As shown in Figure 6D, the
deletion of PAR2 C-terminus completely abolished the ligand-
promoted BRET increase demonstrating its implication in PAR2-
β-arrestin 1 association. Moreover, both trypsin (Figure 6E) and
SLIGRL (Figure 6F) induced β-arrestin 1 recruitment to PAR2
in a dose-dependent manner with similar potencies (Table 2).
These BRET observations clearly show a recruitment of β-arrestin
1 to PAR2 involving the C-terminus of the receptor as previously
shown (28).
DISCUSSION
In this study we investigated the interaction of PAR2 with three
different G protein subunits, Gαi1, Gαo, and Gα12 as well as
β-arrestin1 in live COS-7 cells and in real-time using BRET.
We demonstrated the existence of preassembled PAR2-Gαi1 and
PAR2-Gαo complexes which are nicely activated by trypsin and
SLIGRL (PAR2-selective peptide agonist) indicating the cou-
pling of PAR2 to Gαi1 and Gαo proteins in our model. How-
ever, the association of PAR2 with Gα12 protein was exclu-
sively observed upon receptor activation similarly to β-arrestin1
recruitment suggesting different coupling mode of PAR2 with
Gα12. The dose-response analysis indicated the activation of
PAR2-G protein complexes with the known potencies of both
trypsin and SLIGRL (20). Together, these findings are similar
to what we previously reported on thrombin receptor (PAR1)
(6, 7, 27) as well as other studies with other GPCR-G protein
pairs (8, 31, 32).
The kinetic analysis showed that PAR2 activation led to a
rapid and transient BRET increase between the receptor and
either Gαi1 or Gαo proteins with t 1/2 values fluctuating from 1
to 4 s. Such BRET increase likely reflects conformational changes
within the activated preassembled complexes as shown for PAR1
(6, 7). Also, the rapid activation of the preassembled com-
plexes is rather slower but still consistent with the activation
kinetics observed with other GPCRs (33–35). This is in agree-
ment with the fast kinetic for the activation of these classes of
G proteins leading to rapid modulation of intracellular cAMP
levels. In fact, such GPCR-G protein pre-assembly has been
reported to be important to favor a certain GPCR-G protein sto-
ichiometry required for rapid and targeted downstream cellular
responses (36).
Moreover, long-term kinetic analysis revealed that the rapid
agonist-induced activation of PAR2-Gαi/Gαo complexes is fol-
lowed by the desensitization in time-dependent manner of the
preassembled complexes. These observations are supported by
the assessment of β-arrestin 1 recruitment to the activated
PAR2 which showed a time-dependent association between PAR2
and β-arrestin 1 upon receptor activation with either trypsin
or SLIGRL. Moreover, we further demonstrated the impor-
tance of PAR2 C-terminus for such interaction as previously
reported (18, 30).
For the interaction with Gα12 protein, the data with PAR2 sup-
port our previous data with PAR1 (7). This G protein seems to
be recruited to PAR2 according to an agonist-dependent process
with recruitment kinetics similar to that of β-arrestin 1 (Table 1).
This kinetics may be reconciled with the kinetics the activa-
tion of the small G protein RhoA and p115RhoGEF, two major
protein effectors of G12/13 family (37, 38), as well as the involve-
ment of G12/13 in slow and long-term cellular responses such
as proliferation, differentiation, and migration (39, 40). How-
ever, our previous study clearly indicated that slow and sustained
Gα12 recruitment cannot be considered general to all GPCRs
since its pre-assembly has been demonstrated with other GPCRs
(7). Therefore, whether such pre-assembly with Gαi1/o versus
agonist-dependent Gα12 recruitment constitute a general feature
of protease-activated receptor family or rather reflect similarities
in G protein coupling between PAR1 and PAR2 this needs further
investigations. Our study demonstrating the functional interac-
tion of PAR2 with Gαi1, Gαo, and Gα12 in COS-7 cells, in a
similar way to PAR1 (6, 7) shed more light on the G protein
coupling of PAR2. Our observations are in agreement with the
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FIGURE 6 | Recruitment of β-arrestin 1 to the activated PAR2 studied by
BRET. Time-course analysis on BRET signals measured in COS-7 cells
transiently co-expressing Rluc-β-arrestin 1 and either PAR2-YFP (A,B,C) or
PAR2-∆C-YFP (D) in the absence () or presence of 100 nM of trypsin (•) or
10µM of SLIGRL (∆). (C) Represents the normalization of the curves in
(A,B) together on the percentage of the maximal ligand-induced BRET signals
and the curves were fitted by Prism GraphPad fits of trypsin-induced BRET
increase using “One phase exponential association” equation
(Y =Y max*(1−exp(−K *X ))). Dose-response analysis on the increase of BRET
signals between Rluc-β-arrestin 1 and PAR2-YFP upon stimulation with
increasing concentrations of trypsin (E) or SLIGRL (F) as indicated. Data are
means±SEM of three independent experiments performed in duplicate.
previous studies showing the coupling of PAR2 to Gαi1 in the
rabbit gastric muscle cells (24) as well as PAR2 forming a stable
complex with Gα12 in COS-7 cells (25). However, the latter also
reported that PAR2 did not activate Gαi1- and Gαo-dependent
signaling pathways (25) illustrating the complexity of PAR2-G
protein coupling which appears to be strongly dependent on the
cellular model considered.
Finally, our study further illustrates that the GPCR-G pro-
tein pre-assembly and agonist-dependent G protein recruitment
depend on the receptor-G protein pair and the cellular background
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of the model used. This may constitute an important level of inte-
gration and regulation of the multiple coupling of GPCRs (1,
41–43), especially when considering the new concepts of GPCR
biased signaling and heteromerization.
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